Novo Nordisk’s capital markets day transpires on Thursday, and the pharmaceutical firm has aired some key highlights ahead of the meeting, as announced in a stock notification.
The four main points on the agenda for the day include a focus on how Novo Nordisk can secure growth beyond semaglutide by ”building on core research capabilities and new technology platforms.”
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Ambu board had started headhunting process long before firing of CEO
Thursday’s CEO change had been in the works for a while, says Ambu’s board chair Jørgen Jensen.
Nine new drugs recommended for approval by CHMP at May meeting
During this month’s meeting of the CHMP, the EMA’s expert committee, a total of nine new drugs have been recommended while six drugs have had indication extensions accepted. Two treatments have been rejected.
Britt Meelby Jensen wants to rebuild trust in Ambu
After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.
Outgoing Ambu CEO commends colleagues
”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.
Top news from MedWatch this week
Miss anything?
Laboratory technician for process development and clinical manufacturing 
Clinical Trial Manager 
Quality System Manager 
Analytical Senior Scientist 
Director Global Engineering 
IRT Manager, Clinical Drug Supply 
Project Manager & Scrum Master 
2 Sales Representatives and Product Specialists 
Key Account Manager, Europe and Asia 
(Senior) Drug Substance Specialist 
Nordic Medical Affairs Manager 
Client Talent Acquisition Specialist